Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Screening for Type 2 Diabetes in Unconventional Settings Simplified

By LabMedica International staff writers
Posted on 15 Sep 2011
A simple blood test at high street opticians could help to diagnose diabetes. More...
People who do not routinely visit their GP could also be screened in their chiropodist's or dentist's office, or even in pharmacies.

A pilot study, carried out by the Center for Integrated Healthcare Research, School of Medicine and Health, Wolfson Research Institute, Durham University (Stockton-on-Tees, United Kingdom) and The William Kelly Diabetes Center, The James Cook University Hospital, (Middlesbrough, United Kingdom) focused on opticians.
Out of 1,000 people visiting their opticians for an eye test who were found to have one or more risk factors of diabetes, such as increased body mass index or aged over 40, almost 32% were referred to their GP for further investigation after having their blood glucose levels checked.

Currently, most screening for diabetes is carried out in medical settings, mostly by family doctors, but there are many people who do not visit their GP for preventative care, even if they are in an at-risk group. The pilot study indicates that opticians are an under-utilized resource in the efforts to identify the large numbers of people with undiagnosed diabetes.

The findings of this study were published in the July 1, 2011, British Journal of General Practice. Lead author Dr Jenny Howse from Durham University's School of Medicine and Health, said, "The screening test is less invasive and time consuming than fasting blood glucose and oral glucose tolerance tests. Already pharmacists and chiropodists have shown it is feasible to offer screening in their practices, here in the UK as well as in Australia and Switzerland. In the US, 60% of adults visit dentists at least once a year for standard check-ups and those practices could be suitable locations to screen for diabetes."

"In the UK, our initial results show screening for diabetes in opticians is a feasible option but we now need to look at the practicalities of delivering it, including liaison between opticians and GPs and the time costs for opticians."

Related Links:

Durham University




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.